JP3623150004
JP3623150004
TOWA PHARMACEUTICAL CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 178.2B EUR | 188.05B EUR | 204.79B EUR |
Enterprise Value | 365.9B EUR | 188.05B EUR | 386.22B EUR |
Valuation Multiples | |||
Trailing P/E | 21.56x | -- | -- |
Forward P/E | 12.28x | -- | -- |
Price to Sales | 0.64x | -- | -- |
Price to Book | 0.98x | -- | 1.15x |
EV/Revenue | 1.31x | -- | -- |
EV/EBITDA | 7.77x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -9.09% | -- | -- |